Orphan drugs

Track this topic across federal Congress bills, then open each bill page for full context and activity.

Matched bills
7
Coverage
107th-110th
Current view
109th Congress
Congress Filter
Switch views to focus this topic by Congress.
Bills In This Topic
7 results.
Click any row to open the federal bill page.
Bill Title Congress Status Action Date
HR 5115
U.S. Healthcare Technologies Competitiveness Act of 2006
109th Referred to the House Committee on Ways and Means. April 6, 2006
HR 5080
Orphan Drug Tax Credit Act of 2006
109th Referred to the House Committee on Ways and Means. April 4, 2006
HR 417
Medical Innovation Prize Act of 2005
109th Referred to the Subcommittee on Courts, the Internet, and Intellectual Property. March 2, 2005
S 4040
Public Research in the Public Interest Act of 2006
109th Read twice and referred to the Committee on the Judiciary. (text of measure as introduced: CR S10743-10745) September 29, 2006
S 2564
Biodefense and Pandemic Vaccine and Drug Development Act of 2006
109th Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S3222-3227) April 6, 2006
S 1873
Biodefense and Pandemic Vaccine and Drug Development Act of 2005
109th Placed on Senate Legislative Calendar under General Orders. Calendar No. 257. October 24, 2005
S 975
Project BioShield II Act of 2005
109th Committee on Health, Education, Labor, and Pensions. Held a roundtable discussion of the bill. July 21, 2005